NASDAQ: ZNTL
Zentalis Pharmaceuticals Inc Earnings Dates, Reports, Calls

Zentalis Pharmaceuticals earnings were -$165.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ZNTL earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$47.5M, up 18.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ZNTL reported annual earnings of -$165.8M, with -43.2% growth. The next ZNTL earnings date is May 5, 2025.

ZNTL earnings history

Current Revenue
$0.0
Current Earnings
-$165.8M
Current Profit Margin
0%

ZNTL Return on Equity

Current Company
-43.3%
Current Industry
-2%
Current Market
34.1%
ZNTL's Return on Equity (-43.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ZNTL undefined

Current Company
-34.4%
Current Industry
-0.4%
ZNTL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZNTL announces earnings.

ZNTL undefined

Current Company
-43.87%
Current Industry
5.9%
ZNTL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZNTL vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZNTL-$164.37M-$165.84MN/A-$2.33
ALEC-$110.08M-$119.05MN/A-$1.23
TNXP-$126.62M-$130.04MN/A-$176.60
CCCC-$96.95M-$105.32MN/A-$1.52
COYA-$15.57M-$14.88MN/A-$0.98

ZNTL earnings dates

Next earnings date
May 5, 2025

Zentalis Pharmaceuticals Earnings Reports & History FAQ

What were Zentalis Pharmaceuticals's earnings last quarter?

On ZNTL's earnings call on Invalid Date, Zentalis Pharmaceuticals (NASDAQ: ZNTL) reported Q4 2024 earnings per share (EPS) of -$0.66, up 20.48% year over year. Total ZNTL earnings for the quarter were -$47.47 million. In the same quarter last year, Zentalis Pharmaceuticals's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Zentalis Pharmaceuticals stock.

When does Zentalis Pharmaceuticals report earnings?

The next ZNTL earnings call is Invalid Date. Add ZNTL to your watchlist to be reminded of Zentalis Pharmaceuticals's next earnings date.

What was ZNTL's earnings growth in the past year?

As of Zentalis Pharmaceuticals's earnings date in Invalid Date, Zentalis Pharmaceuticals's earnings has grown year over year. ZNTL earnings in the past year totalled -$165.84 million.

Is Zentalis Pharmaceuticals profitable or losing money?

As of the last Zentalis Pharmaceuticals earnings report, Zentalis Pharmaceuticals is currently losing money. Zentalis Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$165.84 million, a 43.24% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.